Indegene Limited

Indegene Limited (INDGN) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Healthcare Services›Healthcare Research, Analytics & Technology

indegene.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹600.15
Market cap
14,409 Cr
Stock P/E
35.9
P/B
4.59
Dividend yield
0.3%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales673 Cr677 Cr687 Cr720 Cr756 Cr761 Cr804 Cr942 Cr1,003 Cr1,063 Cr
Operating expenses (approx.)534 Cr548 Cr561 Cr589 Cr608 Cr606 Cr664 Cr783 Cr840 Cr889 Cr
EBITDA139 Cr129 Cr126 Cr132 Cr148 Cr155 Cr141 Cr160 Cr164 Cr174 Cr
OPM %20.6%19.1%18.4%18.3%19.5%20.4%17.5%16.9%16.3%16.4%
Other income23 Cr23 Cr21 Cr38 Cr26 Cr22 Cr20 Cr19 Cr11 Cr29 Cr
Interest12 Cr12 Cr4 Cr3 Cr3 Cr4 Cr4 Cr5 Cr7 Cr6 Cr
Depreciation19 Cr20 Cr19 Cr20 Cr21 Cr22 Cr23 Cr40 Cr42 Cr44 Cr
Profit before tax134 Cr120 Cr124 Cr146 Cr149 Cr152 Cr133 Cr135 Cr105 Cr153 Cr
Tax %29.0%26.7%26.1%25.0%21.2%23.5%23.3%23.6%24.2%23.9%
Net profit95 Cr88 Cr92 Cr110 Cr118 Cr116 Cr102 Cr103 Cr80 Cr116 Cr
EPS (₹)₹4.27₹3.79₹3.84₹4.59₹4.91₹4.86₹4.26₹4.29₹3.32₹4.84

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales2,590 Cr2,839 Cr3,511 CrSign in for TTM
Operating expenses (approx.)2,084 Cr2,305 Cr2,892 CrSign in for TTM
EBITDA505 Cr534 Cr619 CrSign in for TTM
OPM %19.5%18.8%17.6%Sign in for TTM
Other income76 Cr107 Cr72 CrSign in for TTM
Interest49 Cr22 Cr19 CrSign in for TTM
Depreciation76 Cr80 Cr126 CrSign in for TTM
Profit before tax459 Cr539 Cr525 CrSign in for TTM
Tax %26.6%24.6%23.6%Sign in for TTM
Net profit337 Cr407 Cr401 CrSign in for TTM
EPS (₹)₹15.19₹17.15₹16.72Sign in for TTM
Dividend payout %0.0%0.0%12.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital44 Cr48 Cr48 Cr
Reserves1,385 Cr2,568 Cr3,091 Cr
Borrowings403 Cr——
Other liabilities713 Cr710 Cr1,482 Cr
Total liabilities2,546 Cr3,326 Cr4,620 Cr
Fixed assets (net)114 Cr135 Cr194 Cr
CWIP—4 Cr12 Cr
Investments797 Cr1,290 Cr1,100 Cr
Trade receivables648 Cr751 Cr982 Cr
Cash & bank189 Cr241 Cr301 Cr
Other assets798 Cr905 Cr2,032 Cr
Total assets2,546 Cr3,326 Cr4,620 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity508 Cr442 Cr651 Cr
Cash from investing-327 Cr-683 Cr-512 Cr
Cash from financing-66 Cr288 Cr-83 Cr
Net cash flow115 Cr52 Cr60 Cr
Free cash flow (OCF − Capex)497 Cr412 Cr607 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2024Mar 2025Mar 2026
ROCE %27.7%21.5%17.3%
ROE %24.1%15.5%12.8%
Debtor days9196102
Inventory days000
Days payable171219
Cash conversion cycle758483
Debt / equity0.28——
Current ratio2.934.482.41
Net debt / EBITDA0.42-0.45-0.49

Compare with peers

Loading peers…

Indegene Limited (INDGN) Financials | BullKarma